This bill amends section 766.101 of the Florida Statutes, which pertains to medical review committees and their immunity from liability. The definition of a medical review committee is expanded to include additional entities, such as a managing entity as defined in s. 394.9082(2) and their employees or agents, as well as clarifying the roles of various committees in evaluating the quality of health care services. The bill also revises the language regarding the immunity of committee proceedings from being subject to discovery or introduction as evidence in civil or administrative actions against health service providers or managing entities.

Additionally, the bill specifies that while the investigations and records of these committees are protected from being disclosed in legal actions, information that is available from original sources remains discoverable. It also clarifies that individuals who attend committee meetings cannot be compelled to testify about the proceedings, but they can provide testimony on matters within their knowledge, excluding their opinions formed during committee hearings. The act is set to take effect on July 1, 2026.